COVID-19 clinical outcomes and DMT of MS patients and population-based controls.

Longinetti, Elisa; Bower, Hannah; McKay, Kyla A; Englund, Simon; Burman, Joachim; Fink, Katharina; Fogdell-Hahn, Anna; Gunnarsson, Martin; Hillert, Jan; Langer-Gould, Annette; Lycke, Jan; Nilsson, Petra; Salzer, Jonatan; Svenningsson, Anders; Mellergård, Johan; Olsson, Tomas; Piehl, Fredrik; Frisell, Thomas

Longinetti, Elisa; Bower, Hannah; McKay, Kyla A; Englund, Simon; Burman, Joachim; Fink, Katharina; Fogdell-Hahn, Anna; Gunnarsson, Martin; Hillert, Jan; Langer-Gould, Annette; Lycke, Jan; Nilsson, Petra; Salzer, Jonatan; Svenningsson, Anders; Mellergård, Johan; Olsson, Tomas; Piehl, Fredrik; Frisell, Thomas.

Affiliation

Longinetti E; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Bower H; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
McKay KA; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Englund S; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Burman J; Department of Neuroscience, Uppsala University, Uppsala, Sweden.
Fink K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Fogdell-Hahn A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Gunnarsson M; Department of Neurology, Örebro University, Örebro, Sweden.
Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Langer-Gould A; Clinical and Translational Neuroscience, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, USA.
Lycke J; Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden.
Nilsson P; Department of Clinical Sciences, Division of Neurology, Lund University, Lund, Sweden.
Salzer J; Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
Svenningsson A; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Mellergård J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Frisell T; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Ann Clin Transl Neurol ; 9(9): 1449-1458, 2022 09.

Article de En | MEDLINE | ID: mdl-35993445

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Sclérose en plaques Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Ann Clin Transl Neurol Année: 2022 Type de document: Article Pays d'affiliation: Suède

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google